The interferon receptor pathway's role in response and resistance to PD-1 blockade

被引：0
|
作者：
Ribas, Antoni [1 ]
机构：
[1] Univ Calif Los Angeles, Los Angeles, CA USA
来源：
CANCER IMMUNOLOGY RESEARCH | 2017年 / 5卷 / 03期
关键词：
D O I：
10.1158/2326-6074.TUMIMM16-IA10
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
IA10
引用
收藏
页数：2
相关论文
共 50 条
  • [31] An In Sitro Assay to Predict Primary Resistance to PD-1 Blockade
    Kobold, Sebastian
    TRENDS IN MOLECULAR MEDICINE, 2021, 27 (04) : 297 - 298
  • [32] Back to the Drawing Board: Overcoming Resistance to PD-1 Blockade
    Carlisle, Jennifer
    Liu, Yuan
    Leal, Ticiana
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (20)
  • [33] Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma
    Zaretsky, Jesse M.
    Garcia-Diaz, Angel
    Shin, Daniel S.
    Escuin-Ordinas, Helena
    Hugo, Willy
    Hu-Lieskovan, Siwen
    Torrejon, Davis Y.
    Abril-Rodriguez, Gabriel
    Sandoval, Salemiz
    Barthly, Lucas
    Saco, Justin
    Moreno, Blanca Homet
    Mezzadra, Riccardo
    Chmielowski, Bartosz
    Ruchalski, Kathleen
    Shintaku, I. Peter
    Sanchez, Phillip J.
    Puig-Saus, Cristina
    Cherry, Grace
    Seja, N. P. Elizabeth
    Kong, Xiangju
    Pang, Jia
    Berent-Maoz, Beata
    Comin-Anduix, Begona
    Graeber, Thomas G.
    Tumeh, Paul C.
    Schumacher, Ton N. M.
    Lo, Roger S.
    Ribas, Antoni
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (09): : 819 - 829
  • [34] Overcoming Genetically Based Resistance Mechanisms to PD-1 Blockade
    Torrejon, Davis Y.
    Abril-Rodriguez, Gabriel
    Champhekar, Ameya S.
    Tsoi, Jennifer
    Campbell, Katie M.
    Kalbasi, Anusha
    Parisi, Giulia
    Zaretsky, Jesse M.
    Garcia-Diaz, Angel
    Puig-Saus, Cristina
    Cheung-Lau, Gardenia
    Wohlwender, Thomas
    Krystofinski, Paige
    Vega-Crespo, Agustin
    Lee, Christopher M.
    Mascaro, Pau
    Grasso, Catherine S.
    Berent-Maoz, Beata
    Comin-Anduix, Begona
    Hu-Lieskovan, Siwen
    Ribas, Antoni
    CANCER DISCOVERY, 2020, 10 (08) : 1140 - 1157
  • [35] Combining PD-1/PD-L1 blockade with type I interferon in cancer therapy
    Razaghi, Ali
    Durand-Dubief, Mickael
    Brusselaers, Nele
    Bjornstedt, Mikael
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [36] Development of cancer immunotherapy based on PD-1/PD-L1 pathway blockade
    Zhang, Min
    Liu, Kehai
    Wang, Mingfu
    RSC ADVANCES, 2019, 9 (58) : 33903 - 33911
  • [37] Characterization of Immunosuppressive Myeloid Cells in Merkel Cell Carcinoma: Correlation with Resistance to PD-1 Pathway Blockade
    Tabachnick-Cherny, Shira
    Pulliam, Thomas
    Rodriguez, Haroldo J.
    Fan, Xinyi
    Hippe, Daniel S.
    Jones, Daniel C.
    Moshiri, Ata S.
    Smythe, Kimberly S.
    Kulikauskas, Rima M.
    Zaba, Lisa C.
    Paulson, Kelly G.
    Nghiem, Paul
    CLINICAL CANCER RESEARCH, 2024, 30 (06) : 1189 - 1199
  • [38] Drug response to PD-1/PD-L1 blockade: based on biomarkers
    Chen, Qi
    Li, Tianhe
    Yue, Wentao
    ONCOTARGETS AND THERAPY, 2018, 11 : 4673 - 4683
  • [39] Defining tumor resistance to PD-1 pathway blockade: recommendations from the first meeting of the SITC Immunotherapy Resistance Taskforce
    Kluger, Harriet M.
    Tawbi, Hussein A.
    Ascierto, Maria L.
    Bowden, Michaela
    Callahan, Margaret K.
    Cha, Edward
    Chen, Helen X.
    Drake, Charles G.
    Feltquate, David M.
    Ferris, Robert L.
    Gulley, James L.
    Gupta, Shilpa
    Humphrey, Rachel W.
    LaVallee, Theresa M.
    Le, Dung T.
    Hubbard-Lucey, Vanessa M.
    Papadimitrakopoulou, Vassiliki A.
    Postow, Michael A.
    Rubin, Eric H.
    Sharon, Elad
    Taube, Janis M.
    Topalian, Suzanne L.
    Zappasodi, Roberta
    Sznol, Mario
    Sullivan, Ryan J.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (01)
  • [40] Delineating the Role of PD-1/PD-L1 Blockade in Advanced SCLC
    Zimmermann, Stefan
    Peters, Solange
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (09) : 1242 - 1244
12345